Volume 12 Issue 4
Jul.  2021
Turn off MathJax
Article Contents
Article Navigation >  ORGAN TRANSPLANTATION  > 2021  >  12(4): 412-420
Qiao Bingbing, Li Shipeng, Song Haosen, et al. Effect of phosphoglycerate mutase 5 mediated pyroptosis on liver ischemia-reperfusion injury[J]. ORGAN TRANSPLANTATION, 2021, 12(4): 412-420. doi: 10.3969/j.issn.1674-7445.2021.04.007
Citation: Qiao Bingbing, Li Shipeng, Song Haosen, et al. Effect of phosphoglycerate mutase 5 mediated pyroptosis on liver ischemia-reperfusion injury[J]. ORGAN TRANSPLANTATION, 2021, 12(4): 412-420. doi: 10.3969/j.issn.1674-7445.2021.04.007
shu

Effect of phosphoglycerate mutase 5 mediated pyroptosis on liver ischemia-reperfusion injury

doi: 10.3969/j.issn.1674-7445.2021.04.007

  • Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China

More Information
  • Corresponding author: Qiao Bingbing, Email: popzxcbb@126.com
  • Received Date: 2021-03-27
    Available Online: 2021-07-13
  • Publish Date: 2021-07-15
    Abstract
  •   Objective  To investigate the effect and its molecular mechanism of phosphoglycerate mutase 5 (PGAM5) mediated pyroptosis on liver ischemia-reperfusion injury (IRI).  Methods  C57 mouse models of liver IRI were established and randomly divided into the 6 h reperfusion (6 h group) and 12 h reperfusion (12 h group), and sham operation group (sham group) was established too, 10 rats in each group. The effect of IRI on the parameters in the liver tissues and serum samples was evaluated. The expression levels of PGAM5 and cysteinyl aspartate specific proteinase (Caspase)-1 in the liver tissues during IRI were quantitatively detected. The IRI models of liver cells were established (IRI group). The IRI models of liver cells were established after pretreatment with Caspase-1 inhibitor Z-YVAD-FMK (inhibitor group). The untreated AML12 cells were allocated into the control group. The effect of inhibiting Caspase-1 activity on pyroptosis was analyzed. AML12 cells were transfected with PGAM5 small interfering ribonucleic acid (siRNA) (siRNA group) and siRNA-negative control (siRNA-NC) (siRNA-NC group) by liposome 3000, and then IRI models of liver cells were established. The untreated AML12 cells were assigned into the control group. The effect of PGAM5 mediated pyroptosis on IRI of liver cells was assessed.  Results  In the 6 h and 12 h groups, partial liver cell edema, hepatic sinusoid narrowing, central vein congestion and occasional spot necrosis were observed in the mouse liver tissues, and these changes in the 12 h group were more aggravated than those in the 6 h group. The serum levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in the 6 h and 12 h groups were higher than those in the sham group, and the values in the 12 h group were higher than those in the 6 h group. The levels of tumor necrosis factor (TNF)-α and interleukin (IL)-1β were increased in the 6 h and 12 h groups, and the values in the 12 h group were lower than those in the 6 h group. The relative expression levels of IL-1β messenger ribonucleic acid (mRNA) in the mouse liver tissues in the 6 h and 12 h groups were up-regulated, and the value in the 12 h group was lower than that in the 6 h group. The cell apoptosis rates in the liver tissues were significantly increased in the 6 h and 12 h groups, and the value in the 12 h group was remarkably lower than that in the 6 h group (P < 0.01-0.05). Compared with the sham group, the relative expression levels of PGAM5 mRNA and protein in the mouse liver tissues in the 6 h and 12 h groups were significantly up-regulated, and the values in the 12 h group were significantly higher than those in the 6 h group (P < 0.01-0.05). The protein expression levels of PGAM5 and Caspase-1 in the liver tissues were up-regulated in the 6 h and 12 h groups. Compared with the control group, the relative expression levels of NOD-like receptor protein 3 (NLRP3), cleaved Caspase-1 and Gasdermin D (GSDMD) proteins were up-regulated and the fluorescence intensity of GSDMD was increased in the IRI group. Compared with the IRI group, the relative expression levels of NLRP3, cleaved Caspase-1 and GSDMD proteins were significantly down-regulated and the fluorescence intensity of GSDMD was considerably decreased in the inhibitor group (P < 0.01-0.05). Compared with the control group, the cell survival rate was significantly decreased, and the relative expression levels of PGAM5, NLRP3, cleaved Caspase-1 and GSDMD proteins were significantly up-regulated in the siRNA-NC group (P < 0.01-0.05). Compared with the siRNA-NC group, the cell survival rate was remarkably increased, whereas the relative expression levels of PGAM5, NLRP3, cleaved Caspase-1 and GSDMD proteins were significantly down-regulated in the siRNA group (P < 0.01-0.05).  Conclusions  PGAM5 may aggravate the liver IRI in mouse models probably by mediating pyroptosis via PGAM5/Caspase-1/GSDMD signaling pathway and aggravating liver cell injury.

     

    • FullText(HTML)
  • loading
    • References(30)
  • [1]
    NEMETH N, PETO K, MAGYAR Z, et al. Hemorheological and microcirculatory factors in liver ischemia-reperfusion injury-an update on pathophysiology, molecular mechanisms and protective strategies[J]. Int J Mol Sci, 2021, 22(4): 1864. DOI: 10.3390/ijms22041864.
    [2]
    DOSSI CG, VARGAS RG, VALENZUELA R, et al. Beneficial effects of natural compounds on experimental liver ischemia-reperfusion injury[J]. Food Funct, 2021, 12(9): 3787-3798. DOI: 10.1039/d1fo00289a.
    [3]
    CHEN X, ZHANG J, XIA L, et al. β-Arrestin-2 attenuates hepatic ischemia-reperfusion injury by activating PI3K/Akt signaling[J]. Aging (Albany NY), 2020, 13(2): 2251-2263. DOI: 10.18632/aging.202246.
    [4]
    WANG LX, ZHU XM, LUO YN, et al. Sestrin2 protects dendritic cells against endoplasmic reticulum stress-related apoptosis induced by high mobility group box-1 protein[J]. Cell Death Dis, 2020, 11(2): 125. DOI: 10.1038/s41419-020-2324-4.
    [5]
    WEN S, LI X, LING Y, et al. HMGB1-associated necroptosis and Kupffer cells M1 polarization underlies remote liver injury induced by intestinal ischemia/reperfusion in rats[J]. FASEB J, 2020, 34(3): 4384-4402. DOI: 10.1096/fj.201900817R.
    [6]
    GONG J, WANG J, TIAN Y, et al. Expression of tubulin folding cofactor B in mouse hepatic ischemia-reperfusion injury[J]. Biomed Rep, 2017, 6(5): 525-531. DOI: 10.3892/br.2017.891.
    [7]
    CUI Z, LI S, LIU Z, et al. Interferon regulatory factor 1 activates autophagy to aggravate hepatic ischemia-reperfusion injury by increasing high mobility group box 1 release[J]. Cell Physiol Biochem, 2018, 48(1): 328-338. DOI: 10.1159/000491732.
    [8]
    WANG X, MARETTI-MIRA AC, WANG L, et al. Liver-selective MMP-9 inhibition in the rat eliminates ischemia-reperfusion injury and accelerates liver regeneration[J]. Hepatology, 2019, 69(1): 314-328. DOI: 10.1002/hep.30169.
    [9]
    郑健豪, 戴朝六. 缺血再灌注损伤对肝癌的影响及作用机制[J]. 临床肝胆病杂志, 2019, 35(6): 1369-1373. DOI: 10.3969/j.issn.1001-5256.2019.06.042.

    ZHENG JH, DAI CL. Influence of ischemia-reperfusion injury on liver cancer and related mechanism[J]. J Clin Hepatol, 2019, 35(6): 1369-1373. DOI:10.3969/j.issn. 1001-5256.2019.06.042.
    [10]
    王敬元, 李生伟, 龚建平, 等. 沉默信息调节因子1在肝脏缺血再灌注损伤中的作用[J]. 临床肝胆病杂志, 2019, 35(6): 1388-1391. DOI:10.3969/j.issn.1001-5256. 2019.06.047.

    WANG JY, LI SW, GONG JP, et al. Role of silent information regulator 1 in hepatic ischemia-reperfusion injury[J]. J Clin Hepatol, 2019, 35(6): 1388-1391. DOI: 10.3969/j.issn.1001-5256.2019.06.047.
    [11]
    YÜCEL A, AYDOGAN MS, UCAR M, et al. Effects of apocynin on liver ischemia-reperfusion injury in rats[J]. Transplant Proc, 2019, 51(4): 1180-1183. DOI: 10.1016/j.transproceed.2019.01.108.
    [12]
    SUN XL, ZHANG YL, XI SM, et al. MiR-330-3p suppresses phosphoglycerate mutase family member 5 -inducted mitophagy to alleviate hepatic ischemia-reperfusion injury[J]. J Cell Biochem, 2019, 120(3): 4255-4267. DOI: 10.1002/jcb.27711.
    [13]
    YANG C, LIU X, YANG F, et al. Mitochondrial phosphatase PGAM5 regulates Keap1-mediated Bcl-xL degradation and controls cardiomyocyte apoptosis driven by myocardial ischemia/reperfusion injury[J]. In Vitro Cell Dev Biol Anim, 2017, 53(3): 248-257. DOI: 10.1007/s11626-016-0105-2.
    [14]
    REMIJSEN Q, GOOSSENS V, GROOTJANS S, et al. Depletion of RIPK3 or MLKL blocks TNF-driven necroptosis and switches towards a delayed RIPK1 kinase-dependent apoptosis[J]. Cell Death Dis, 2014, 5(1): e1004. DOI: 10.1038/cddis.2013.531.
    [15]
    DIAMOND CE, LEONG KWK, VACCA M, et al. Salmonella typhimurium-induced IL-1 release from primary human monocytes requires NLRP3 and can occur in the absence of pyroptosis[J]. Sci Rep, 2017, 7(1): 6861. DOI: 10.1038/s41598-017-07081-3.
    [16]
    LIU J, DU S, KONG Q, et al. HSPA12A attenuates lipopolysaccharide-induced liver injury through inhibiting Caspase-11-mediated hepatocyte pyroptosis via PGC-1α-dependent acyloxyacyl hydrolase expression[J]. Cell Death Differ, 2020, 27(9): 2651-2667. DOI: 10.1038/s41418-020-0536-x.
    [17]
    WEI X, PENG H, DENG M, et al. MiR-703 protects against hypoxia/reoxygenation-induced cardiomyocyte injury via inhibiting the NLRP3/Caspase-1-mediated pyroptosis[J]. J Bioenerg Biomembr, 2020, 52(3): 155-164. DOI: 10.1007/s10863-020-09832-w.
    [18]
    YU B, MA J, LI J, et al. Mitochondrial phosphatase PGAM5 modulates cellular senescence by regulating mitochondrial dynamics[J]. Nat Commun, 2020, 11(1): 2549. DOI: 10.1038/s41467-020-16312-7.
    [19]
    邓晶晶, 李婷婷, 张佳月, 等. 阿托伐他汀通过MaxiK通道介导HepG2细胞焦亡[J]. 实用医学杂志, 2019, 35(13): 2056-2060. DOI: 10.3969/j.issn.1006-5725.2019.13.006.

    DENG JJ, LI TT, ZHANG JY, et al. Effect of atorvastatin on the focal death of HepG2 cells was mediated by the MaxiK channel[J]. J Pract Med, 2019, 35(13): 2056-2060. DOI: 10.3969/j.issn.1006-5725.2019.13.006.
    [20]
    HACHIM MY, KHALIL BA, ELEMAM NM, et al. Pyroptosis: the missing puzzle among innate and adaptive immunity crosstalk[J]. J Leukoc Biol, 2020, 108(1): 323-338. DOI: 10.1002/JLB.3MIR0120-625R.
    [21]
    AN S, HU H, LI Y, et al. Pyroptosis plays a role in osteoarthritis[J]. Aging Dis, 2020, 11(5): 1146-1157. DOI: 10.14336/AD.2019.1127.
    [22]
    ZHAO H, HUANG H, ALAM A, et al. VEGF mitigates histone-induced pyroptosis in the remote liver injury associated with renal allograft ischemia-reperfusion injury in rats[J]. Am J Transplant, 2018, 18(8): 1890-1903. DOI: 10.1111/ajt.14699.
    [23]
    LI Z, ZHAO F, CAO Y, et al. DHA attenuates hepatic ischemia reperfusion injury by inhibiting pyroptosis and activating PI3K/Akt pathway[J]. Eur J Pharmacol, 2018, 835: 1-10. DOI: 10.1016/j.ejphar.2018.07.054.
    [24]
    EL-SISI AEE, SOKAR SS, SHEBL AM, et al. Octreotide and melatonin alleviate inflammasome-induced pyroptosis through inhibition of TLR4-NF-κB-NLRP3 pathway in hepatic ischemia/reperfusion injury[J]. Toxicol Appl Pharmacol, 2021, 410: 115340. DOI: 10.1016/j.taap.2020.115340.
    [25]
    HUA S, MA M, FEI X, et al. Glycyrrhizin attenuates hepatic ischemia-reperfusion injury by suppressing HMGB1-dependent GSDMD-mediated Kupffer cells pyroptosis[J]. Int Immunopharmacol, 2019, 68: 145-155. DOI: 10.1016/j.intimp.2019.01.002.
    [26]
    LI J, ZHAO J, XU M, et al. Blocking GSDMD processing in innate immune cells but not in hepatocytes protects hepatic ischemia-reperfusion injury[J]. Cell Death Dis, 2020, 11(4): 244.
    [27]
    TONNUS W, LINKERMANN A. Gasdermin D and pyroptosis in acute kidney injury[J]. Kidney Int, 2019, 96(5): 1061-1063. DOI: 10.1016/j.kint.2019.07.002.
    [28]
    SHI J, GAO W, SHAO F. Pyroptosis: Gasdermin-mediated programmed necrotic cell death[J]. Trends Biochem Sci, 2017, 42(4): 245-254. DOI: 10.1016/j.tibs. 2016.10.004.
    [29]
    KUANG S, ZHENG J, YANG H, et al. Structure insight of GSDMD reveals the basis of GSDMD autoinhibition in cell pyroptosis[J]. Proc Natl Acad Sci U S A, 2017, 114(40): 10642-10647. DOI: 10.1073/pnas.1708194114.
    [30]
    MORIWAKI K, FARIAS LUZ N, BALAJI S, et al. The mitochondrial phosphatase PGAM5 is dispensable for necroptosis but promotes inflammasome activation in macrophages[J]. J Immunol, 2016, 96(1): 407-415. DOI: 10.4049/jimmunol.1501662.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(5)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (774) PDF downloads(63) Cited by()
    Proportional views
    Related

    WeChat Subscription Account

    Wechat Service Account

    Contact Us
    • Tel：020-38736410
    • Email: organtranspl@163.com
    • Address：The Third Affiliated Hospital of Sun Yat-sen University, No. 600, Tianhe Road, Tianhe District, Guangzhou
    • Editorial Office of Organ Transplantation  粤ICP备2021030844号
    Links

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return